Veritas Farms Inc. (OTCMKTS : VFRM) Q4 2020 earnings call dated Sep. 17, 2020 Corporate Participants: Derek Thomas -- Vice President Of Business Development
Veritas Farms Inc. (VFRM) Q4 2020 Earnings Call Transcript
Veritas Farms Inc. (OTCMKTS : VFRM) Q4 2020 earnings call dated Sep. 17, 2020 Corporate Participants: Derek Thomas -- Vice President Of Business Development
Silence Therapeutics PLC (LON: SLN) Q2 2020 earnings call dated Sep. 14, 2020 Corporate Participants: Gem Hopkins -- Head of Investor Relations and Corporate
NovoCure Limited (NASDAQ: NVCR) Q2 2020 earnings call dated Jul. 30, 2020 https://www.youtube.com/watch?v=f1kpNPlyXaE&t=455s Corporate Participants: Ashley Cordova -- Senior Vice President of Finance &
Cannabis was recognized as an essential business in several markets when the shutdown came into effect, including Canada and some US states,
Tilray Inc. (NASDAQ: TLRY) Q2 2020 earnings call dated Aug. 10, 2020 Corporate Participants: Raphael Gross -- Investor Relations Brendan Kennedy -- Chief Executive Officer Michael
It's been a disappointing first half for drugstore chain operators. However, after reporting better-than-expected top and bottom line figures for its first
Neptune Wellness Solutions Inc (NEPT) Q4 2020 earnings call dated June 10, 2020 Corporate Participants: Scott Van Winkle -- Investor Relations, ICR Michael Cammarata -- President
Zoetis Inc (ZTS) Q1 2020 earnings call dated May 06, 2020 Corporate Participants: Steven Frank -- Investor Relation Kristin Peck -- Executive Vice President and Group
Resmed Inc (RMD) Q3 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Amy Wakeham -- Vice President of Investor Relations and Corporate Communications
IDEXX Laboratories Inc (IDXX) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Jay Mazelsky -- President and Chief Executive Officer Brian P.
For Novavax Inc. (NASDAQ: NVAX), the new fiscal year is of great significance due to the progress it has achieved in developing
Novavax Inc. (NVAX) Q1 2020 earnings call dated May 11, 2020 Corporate Participants: Erika Trahan -- Investor Relations Stanley C. Erck -- President and Chief Executive
Novavax, Inc. (NASDAQ: NVAX) today announced its first quarter financial results for the period ended March 31, 2020. NVAX reported net loss
The cannabis market, which has been witnessing issues like low demand and the vaping crisis, is probably headed for a slowdown this
Danaher Corp (DHR) Q1 2020 earnings call dated May 07, 2020 Corporate Participants: Matthew E. Gugino -- Vice President of Investor Relations Thomas P.
Amgen Inc (AMGN) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Arvind Sood -- Vice President of Investor Relations Robert A. Bradway -- Chairman
Illumina Inc (ILMN) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Jacquie Ross -- Vice President of Corporate Communications and Corporate Social
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) Thursday said its first-quarter earnings increased, aided by higher revenues. The results also exceeded the
Medical device maker Abiomed, Inc. (NASDAQ: ABMD) reported a decline in fourth quarter earnings even as revenues remained flat. The company withheld
Waters Corporation (WAT) Q1 2020 earnings call dated Apr. 28, 2020 Corporate Participants: Bryan Brokmeier -- CFA, Senior Director Christopher J. O'Connell -- President and Chief
Accuray Inc (ARAY) Q3 2020 earnings call dated Apr. 28, 2020 Corporate Participants: Joseph Diaz -- Managing Partner Joshua H. Levine -- President and Chief Executive